2026/01/01 by Tianyuan Shi, Kyosuke Mukae, Maya Shindo +5 · 1 voice
Medicine · Biochemistry, Genetics and Molecular Biology · #Neuroblastoma Research and Treatments #Glioma Diagnosis and Treatment #Pluripotent Stem Cells Research
paper · pdf · doi:10.1111/gtc.70083
openalex publication_date 2026/01/01 · openalex created_date 2026/01/22 · openalex updated_date 2026/07/02
Neuroblastoma (NB) is a pediatric solid tumor originating from neural crest cells (NCCs), which are precursors of the sympathetic nervous system. MYCN amplification is a key factor contributing to the poor prognosis of NB. Anaplastic lymphoma kinase (ALK) alterations, including mutations and amplification, activate oncogenic signaling pathways that, together with MYCN amplification, further enhance tumor malignancy. NCCs are mainly classified into cranial NCCs (cNCCs) and trunk NCCs (tNCCs). Recent studies have reported NB development from tNCCs. However, the potential for NB development from cNCCs remains unexplored. In this study, we sought to mimic the tumorigenic process of NB by overexpressing MYCN and ALK in cNCCs derived from human induced pluripotent stem cells. These modified cells, when subcutaneously transplanted into immunodeficient mice, induced NB-like tumors and could thus be used as an in vitro model to study this tumor. Through extensive gene expression profiling and whole-exome sequencing of MYCN/ALK-induced clones, we identified key features of NB, including loss of NF1 and gain of 17q chromosome, which are critical for the development of malignant tumor. This model provides a valuable platform for studying the biological mechanisms driving ALK and MYCN amplification in NB derived from cNCCs.